Officer Roger Adsett files intent to sell $14.46M in company stock
Summary
An officer of INSMED Inc. has filed a Form 144 indicating an intent to sell approximately $14.46 million worth of common stock.
Key Events
-
Officer Files Intent to Sell
Roger Adsett, an officer of INSMED Inc., filed a Form 144 to sell 88,060 shares of common stock.
-
Significant Value
The proposed sale is valued at approximately $14.46 million.
-
Follows Positive News
This intent to sell comes after the company recently announced positive Phase 3b results for ARIKAYCE.
-
Part of Broader Distribution
This filing contributes to a recent pattern of net insider distribution totaling nearly $15 million over the last 90 days.
Analysis
Roger Adsett, an officer at INSMED Inc., has filed a Form 144 indicating an intent to sell 88,060 shares of common stock, valued at approximately $14.46 million. While this represents a small percentage of the company's large market capitalization, it is a substantial dollar amount for an individual insider. This intent to sell follows a period of net insider distribution for the company and comes shortly after the company announced positive Phase 3b results for ARIKAYCE, which could be seen as an opportune time for an insider to monetize holdings. Investors should monitor subsequent Form 4 filings for actual sales.
At the time of this filing, INSM was trading at $165.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $35.5B. The 52-week trading range was $60.40 to $212.75. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.